Barclays Maintains Overweight on HealthEquity, Raises Price Target to $115

Benzinga Newsdesk www.benzinga.com Positive 79.9%

Neg 0% Neu 0% Pos 79.9%

Barclays analyst Peter Warendorf maintains HealthEquity (NASDAQ:HQY) with a Overweight and raises the price target from $110 to $115.